Hughes Hubbard, S&C Advise on Merck's Idenix Buy

Moving to expand its product offerings aimed at treating hepatitis C, pharmaceutical giant Merck & Co. announced Monday that it has agreed to buy Cambridge, Ma.-based Idenix Pharmaceuticals Inc. for $3.85 billion.

Sign up for a free Law.com trial now!

Law.com's Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on Law.com
  • The free Law.com InPractice digital newsletter
  • Personalized legal news on the Law.com mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Law.com Newswire digital newsletter.